Deus Ex Machina
Douglas L. Mann, MD, FACC
JACC: Basic to Translational Science · 2017
doi:10.1016/j.jacbts.2017.03.001 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Translational research serves as the critical bridge between target identification and early-phase clinical studies that provide critical go/no-go decisions for larger and more expensive phase III clinical trials. Insofar as translational clinical studies are smaller, they are inherently fragile by
Abstract licence: CC BY-NC-ND
References2
- 1.Corrected
1 more reference, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.